Part D Drug Plans Are Tightening Rules — Making It Harder to Get Brand‑Name Medications

Recent changes to Medicare Part D could have an impact on your wallet and your care, especially if you rely on brand-name drugs. While some updates are designed to lower overall costs, they’re also quietly making it harder for many patients to access certain medications. Insurance companies are adjusting formularies, increasing deductibles, and shifting how drugs are covered. For seniors who are on a fixed income, these changes can be stressful. Here is what is happening behind the scenes and how it could impact your access to medications.

Formularies Are Changing And Brand-Name Drugs Are Moving Tiers

One of the biggest shifts in Medicare Part D is how plans organize their drug formularies. Each year, insurers can change which medications they cover and how they categorize them. Brand-name drugs are increasingly being moved to higher tiers, which means higher copays or coinsurance.

In some cases, drugs may be removed from coverage entirely or replaced with preferred alternatives. This creates a situation where patients must either pay more or switch medications. For many seniors, that decision isn’t always simple or medically ideal.

Higher Deductibles Are Making Brand Drugs More Expensive Upfront

Another key change in Medicare Part D is the rising deductible. In 2026, the maximum deductible has increased to about $615, meaning patients must pay more before coverage kicks in.

This particularly impacts brand-name medications, which tend to fall into higher-cost tiers. Patients may have to pay hundreds of dollars out of pocket early in the year. Even if costs level out later, that initial burden can be a major barrier. For those on fixed incomes, this change can be especially challenging.

Coinsurance Is Replacing Flat Copays

Many Medicare Part D plans are shifting from predictable copays to percentage-based coinsurance. Instead of paying a flat fee, patients now pay a percentage of the drug’s total cost.

For expensive brand-name drugs, this can lead to significantly higher out-of-pocket expenses. A medication that once cost $40 might now cost hundreds, depending on its price. This shift makes budgeting for prescriptions much more difficult. It also disproportionately affects those who rely on specialty or brand-name medications.

Fewer Plan Options Mean Less Flexibility

Another major change is the shrinking number of available Medicare Part D plans. The total number of standalone plans has dropped significantly, reducing consumer choice.

With fewer options, it becomes harder to find a plan that covers specific brand-name medications affordably. Some insurers are also exiting the market entirely, further limiting choices. This lack of competition can lead to stricter coverage rules and less flexibility for patients. For seniors, it means fewer ways to shop around for better coverage.

Drug Price Negotiations Favor Select Medications Only

The Inflation Reduction Act introduced a major change: Medicare can now negotiate prices for certain high-cost drugs. In 2026, the first round of negotiated prices applies to a limited group of medications.

While this is great news for those specific drugs, it doesn’t apply to most brand-name medications. This creates a gap where some drugs become more affordable, while others remain expensive or harder to access. In some cases, plans may steer patients toward negotiated drugs instead of others. That can limit treatment options depending on what your doctor prescribes.

New Cost Caps Help But Don’t Solve Access Issues

One positive change in Medicare Part D is the introduction of an annual out-of-pocket cap. In 2026, drug costs are capped at $2,100, after which plans cover 100% of covered medications.

While this provides long-term financial relief, it doesn’t eliminate upfront costs or coverage restrictions. Patients still have to navigate deductibles, coinsurance, and formulary limitations before reaching that cap. For those who need expensive brand-name drugs early in the year, costs can still be steep. This means access challenges remain despite the new protections.

What Seniors Should Do to Protect Their Coverage

If you’re enrolled in Medicare Part D, staying on top of things is more important than ever. Be sure you review your plan’s Annual Notice of Changes each year to understand how coverage is shifting. Use tools like Medicare’s Plan Finder to compare options and ensure your medications are covered. Consider discussing alternatives with your doctor if costs become too high. And don’t hesitate to appeal decisions if a needed medication is denied.

The changes to Medicare Part D are a mixed bag, offering cost protections while tightening access to certain medications. Brand-name drugs are becoming harder to access due to higher tiers, stricter rules, and fewer plan options. While reforms aim to control spending, they also shift more responsibility onto patients.

Have you noticed changes in your Medicare Part D coverage or difficulty getting certain medications? Share your experience in the comments!

What to Read Next

5 Ways the $2,100 Part D Cap Works in 2026 (and What It Doesn’t Cover)

Warning for California Seniors: The ‘2026 Medicare Part D’ Phone Call That’s Emptying Bank Accounts

10 Medicare Part D Deductible Rules That Are Costing Retirees More in 2026

AARP Warns: 3 Major Part D Changes Hit Seniors in 2026—From Payment Plans to Drug Rebates

The $2,100 Part D ‘Hard Cap’: Why 4 Million Seniors Will Hit Their Drug Spending Limit by March

Drew Blankenship is a seasoned automotive professional with over 20 years of hands-on experience as a Porsche technician.  While Drew mostly writes about automotives, he also channels his knowledge into writing about money, technology and relationships. Based in North Carolina, Drew still fuels his passion for motorsport by following Formula 1 and spending weekends under the hood when he can. He lives with his wife and two children, who occasionally remind him to take a break from rebuilding engines.